Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822893) titled 'Evaluation of the Effect of Botulinum Toxin on Resting Tremor of the Refractory Upper Limb in Parkinsonians, Cross-over Study, Double Blind and Placebo-controlled' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: University Hospital, Toulouse
Condition:
PARKINSON DISEASE (Disorder)
Intervention:
Drug: Injection of Dysport then placebo
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: October 2026
Target Sample Size: 39 ...